Ridder Titan Genesis Corp. (RTGC) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ridder Titan Genesis Corp. (RTGC) trades at $0.1265. Ridder Titan Genesis Corp. focuses on developing whole plant extractions for cancer and palliative treatments within the medical marijuana sector. Formerly known as UMF Group Inc. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for RTGC: RTGC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RTGC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on RTGC.
How is this calculated? →Ridder Titan Genesis Corp. (RTGC) Financial Services Profile
Ridder Titan Genesis Corp., operating in the shell companies industry within the financial services sector, focuses on developing whole plant extractions for medical marijuana applications. Founded in 1988, the company's small size and OTC market presence present unique investment considerations in a rapidly evolving sector.
What Is the Investment Thesis for RTGC?
Ridder Titan Genesis Corp. presents a speculative investment opportunity within the medical marijuana sector. The company's focus on whole plant extractions for cancer and palliative treatments could offer growth potential if clinical trials and regulatory approvals are successful. However, the company's small market capitalization of $0.00B and negative P/E ratio of -54.27 indicate significant financial challenges. Growth catalysts include potential advancements in medical marijuana research and favorable regulatory changes. Key risks include intense competition, limited access to capital, and the inherent uncertainties of the OTC market. Investors should carefully evaluate the company's financial stability and long-term viability before considering an investment.
Based on FMP financials and quantitative analysis
RTGC Key Highlights
Market capitalization of $0.00B, indicating a micro-cap company with high growth potential but also significant risk.
- P/E ratio of -54.27, reflecting current losses and suggesting the company's earnings are negative.
- Focus on whole plant extractions for cancer and palliative treatments, targeting a niche market within the medical marijuana industry.
- Formerly known as UMF Group Inc., the company rebranded in February 2024, potentially signaling a strategic shift.
- Based in Boulder, Colorado, operating in a state with established medical marijuana regulations.
Who Are RTGC's Competitors?
RTGC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
| MAAQ Mana Capital Acquisition Corp. | $5.99 | -24.18% | $57.0M | 61 |
| RCLFU Rosecliff Acquisition Corp I | $11.33 | +11.74% | $77.2M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RTGC's Key Strengths?
Focus on a niche market within medical marijuana.
- Potential for innovative product development.
- Established presence in Colorado.
- Experienced leadership team.
What Are RTGC's Weaknesses?
Limited financial resources.
- Small market capitalization.
- Dependence on regulatory approvals.
- Limited brand recognition.
What Could Drive RTGC Stock Higher?
Potential advancements in medical marijuana research and development.
- Favorable regulatory changes in key markets.
- Positive clinical trial results for whole plant extractions.
- Increasing acceptance of medical marijuana among healthcare professionals and patients.
- Strategic partnerships and collaborations with established companies.
What Are the Key Risks for RTGC?
Intense competition from established pharmaceutical companies and other cannabis firms.
- Changing regulatory landscape and potential for stricter regulations.
- Limited access to capital and funding challenges.
- Dependence on regulatory approvals for product commercialization.
- Potential product liability issues and reputational risks.
What Are the Growth Opportunities for RTGC?
- Expansion into new markets: As regulations surrounding medical marijuana evolve, Ridder Titan Genesis Corp. could expand its operations into new states and countries. The global medical cannabis market is projected to reach $55 billion by 2026, presenting significant opportunities for growth. Successful market entry would require navigating complex regulatory frameworks and establishing strategic partnerships.
- Development of novel formulations: Investing in research and development to create innovative formulations and delivery methods for its whole plant extractions could provide a competitive edge. This includes exploring targeted therapies for specific cancer types and palliative care applications. The timeline for this growth opportunity depends on research outcomes and regulatory approvals.
- Strategic partnerships and collaborations: Collaborating with established pharmaceutical companies or research institutions could accelerate the development and commercialization of its products. These partnerships could provide access to funding, expertise, and distribution channels. The success of this strategy depends on identifying suitable partners and negotiating mutually beneficial agreements.
- Increased focus on clinical trials: Conducting clinical trials to validate the efficacy and safety of its whole plant extractions could enhance credibility and attract investment. Positive clinical trial results could lead to regulatory approvals and increased market adoption. The timeline for this growth opportunity depends on the duration and outcomes of clinical trials.
- Capitalizing on the growing acceptance of medical marijuana: As societal attitudes towards medical marijuana continue to shift, Ridder Titan Genesis Corp. can capitalize on the increasing acceptance by expanding its product offerings and marketing efforts. This includes educating healthcare professionals and patients about the potential benefits of its products. The timeline for this growth opportunity depends on the pace of societal and regulatory changes.
What Are RTGC's Competitive Advantages?
- Specialized focus on whole plant extractions.
- Potential intellectual property related to formulations.
- Early mover advantage in a niche market.
- Established presence in Colorado's medical marijuana market.
What Does RTGC Do?
Ridder Titan Genesis Corp., formerly known as UMF Group Inc., was established in 1988 and is headquartered in Boulder, Colorado. The company underwent a name change in February 2024, signaling a strategic shift in its business focus. Ridder Titan Genesis Corp. operates within the medical marijuana sector, concentrating on the development of whole plant extractions intended for cancer and palliative treatments. This specialized focus aims to cater to a niche market within the broader healthcare industry, leveraging the potential therapeutic benefits of cannabis-derived compounds. The company's operations are centered around research and development of these extractions, potentially involving cultivation, processing, and formulation activities. As a shell company, Ridder Titan Genesis Corp.'s business activities and financial performance should be closely scrutinized by investors. The company's future success hinges on its ability to navigate the complex regulatory landscape of the medical marijuana industry, secure necessary funding, and effectively commercialize its products.
What Products and Services Does RTGC Offer?
- Develop whole plant extractions for medical marijuana.
- Focus on cancer and palliative treatments.
- Conduct research and development activities.
- Potentially cultivate and process cannabis.
- Formulate cannabis-derived products.
- Operate within the medical marijuana sector.
How Does RTGC Make Money?
- Research and development of medical marijuana extracts.
- Potential cultivation and processing of cannabis plants.
- Formulation and distribution of cannabis-based products.
- Revenue generation through product sales.
What Industry Does RTGC Operate In?
Ridder Titan Genesis Corp. operates within the evolving medical marijuana industry, which is characterized by increasing acceptance and regulatory changes. The market is driven by growing awareness of the potential therapeutic benefits of cannabis. However, the industry faces significant regulatory hurdles, intense competition, and varying levels of acceptance across different regions. Ridder Titan Genesis Corp.'s focus on whole plant extractions positions it within a specialized segment of this market, potentially offering differentiation but also requiring significant research and development investments. The competitive landscape includes both established pharmaceutical companies and smaller cannabis-focused firms.
Who Are RTGC's Key Customers?
- Patients seeking alternative cancer and palliative treatments.
- Healthcare professionals recommending medical marijuana.
- Pharmacies and dispensaries distributing medical marijuana products.
Company Profile
Ridder Titan Genesis Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Boulder, US. The company is led by CEO Bruce A. Thompson. RTGC has traded publicly since 2011.
Key Financial Metrics
Return on equity for Ridder Titan Genesis Corp. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -1.8%, the inverse of the P/E and a quick read on earnings relative to price.
RTGC Financials
Bull Case vs Bear Case
Bull Case
- Focus on a niche market within medical marijuana.
- Potential for innovative product development.
- Established presence in Colorado.
- Experienced leadership team.
Bear Case
- Limited financial resources.
- Small market capitalization.
- Dependence on regulatory approvals.
- Limited brand recognition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
RTGC Latest News
No recent news available for RTGC.
RTGC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RTGC.
Price Targets
Wall Street price target analysis for RTGC.
RTGC MoonshotScore
What does this score mean?
The MoonshotScore rates RTGC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: Bruce A. Thompson
Managing Director
Bruce A. Thompson serves as the managing director of Ridder Titan Genesis Corp., overseeing the company's operations with a team of four employees. Information on his prior experience and education is not available. As managing director, Thompson is responsible for guiding the company's strategic direction and ensuring its operational efficiency. His leadership is crucial for navigating the challenges and opportunities within the medical marijuana sector.
Track Record: Due to limited information, Bruce A. Thompson's track record and key achievements at Ridder Titan Genesis Corp. are unknown. His tenure and the company's milestones under his leadership cannot be assessed at this time. Further information is needed to evaluate his performance and contributions to the company's success.
RTGC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ridder Titan Genesis Corp. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited reporting requirements and may not be subject to the same level of scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to the potential for limited liquidity, lack of transparency, and higher volatility compared to exchange-listed securities.
- OTC Tier: OTC Other
- Limited liquidity and trading volume.
- Lack of financial transparency and disclosure.
- Potential for price manipulation and fraud.
- Higher volatility compared to exchange-listed stocks.
- Limited regulatory oversight and investor protection.
- Verify the company's registration and legal standing.
- Obtain and review available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with the OTC market.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or investigations.
- Company's focus on medical marijuana research and development.
- Established presence in Colorado's medical marijuana market.
- Name change in 2024 to reflect a strategic shift.
- Company's stated focus on cancer and palliative treatments.
- Presence of a CEO and management team.
Common Questions About RTGC (Financial Services)
What does Ridder Titan Genesis Corp. do?
Ridder Titan Genesis Corp. operates within the medical marijuana sector, focusing on the research, development, and potential commercialization of whole plant extractions. These extractions are specifically targeted for use in cancer and palliative treatments. The company's business model involves developing proprietary formulations, potentially cultivating or sourcing cannabis, and navigating the complex regulatory landscape to bring its products to market.
What do analysts say about RTGC stock?
Given Ridder Titan Genesis Corp.'s micro-cap status and OTC listing, formal analyst coverage is unlikely. Investment decisions should be based on independent research and a thorough understanding of the company's financials, business model, and the risks associated with the medical marijuana industry and OTC markets.
What are the main risks for RTGC?
Ridder Titan Genesis Corp. faces several significant risks, including intense competition from larger, more established companies in the medical marijuana sector. The evolving regulatory landscape poses a constant threat, as changes in laws and regulations could impact the company's ability to operate and commercialize its products.
What are the key factors to evaluate for RTGC?
Evaluate RTGC on fundamentals, analyst consensus, and risk factors. Ridder Titan Genesis Corp. presents a speculative investment opportunity within the medical marijuana sector. Not financial advice.
How frequently does RTGC data refresh on this page?
RTGC's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven RTGC's recent stock price performance?
Ridder Titan Genesis Corp. (RTGC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on a niche market within medical marijuana. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RTGC overvalued or undervalued right now?
Ridder Titan Genesis Corp. (RTGC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RTGC before investing?
Before investing in Ridder Titan Genesis Corp. (RTGC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available for Ridder Titan Genesis Corp.
- OTC market investments carry significant risks.
- Medical marijuana industry is subject to regulatory changes.